Subcutaneous DMPA (DMPA-SC) is a three-month injectable contraceptive that is easy to use and uniquely suited for self-injection. Demonstration and practice injections are a key part of training programs for both health workers and self-injecting clients. Based on lessons learned in five countries, this memo summarizes PATH’s recommendations regarding devices for injection demonstration and practice, injection practice models, and waste disposal.
This memo is included as part of PATH's training materials for facility- and community-based family planning providers.
Publication date: March 2020